- Home
- OBIO vs PED Comparison
OBIO vs PED Comparison
Compare OBIO & PED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OBIO | PED |
|---|---|---|
| Founded | 2017 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 246.2M | 239.0M |
| IPO Year | 2020 | 2012 |
Fundamental Metrics
Financial Performance| Metric | OBIO | PED |
|---|---|---|
| Price | $4.74 | $15.64 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | $14.25 | ★ $30.00 |
| AVG Volume (30 Days) | 209.7K | ★ 753.3K |
| Earning Date | 03-12-2026 | 04-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 33.13 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $33,482,000.00 | ★ $39,553,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $305.89 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 1169.22 | 28.49 |
| 52 Week Low | $2.20 | $0.43 |
| 52 Week High | $5.42 | $18.89 |
Technical Indicators
Market Signals| Indicator | OBIO | PED |
|---|---|---|
| Relative Strength Index (RSI) | 59.91 | 77.69 |
| Support Level | $4.08 | $0.54 |
| Resistance Level | $4.88 | $18.89 |
| Average True Range (ATR) | 0.30 | 1.01 |
| MACD | 0.02 | 1.45 |
| Stochastic Oscillator | 87.84 | 82.27 |
Price Performance
Historical ComparisonAbout OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About PED Pedevco Corp.
PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties where there is a long production history, well-defined geology and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties of the company are located in the San Andres formation of the Permian Basin, situated in West Texas and eastern New Mexico (the Permian Basin), and in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming.